General Information
Infectious Disease
Cancer
Topical Microbicides
Immune Modulation and
Inflammation
April 4th 2008:
ImQuest scientists present important HIV Microbicide results at Microbicides 2008 in Delhi, India.
April 1st 2008:
ImQuest publishes results of structure activity relationship study with pyrimidinedione HIV inhibitors.
September 24th 2007:
ImQuest Life Sciences announces the appointment of Robert Schooley, M.D. to its Scientific Advisory Board.
September 21st 2007:
ImQuest Life Sciences announces the appointment of David Ho, M.D. to its Scientific Advisory Board.
September 20th 2007:
ImQuest Life Sciences announces the appointment of Richard J. Whitley, M.D. as Chairman of its Scientific Advisory Board.
April 25th 2007:
ImQuest Life Sciences Receives Grant from International Partnership
for Microbicides to Develop Novel Microbicide
April 25th 2006:
ImQuest Life Sciences Licenses Piperazine Series of Anti-Cancer Therapeutic
Compounds from Samjin Pharmaceutical Co.
*
Name
:
Affiliation
:
Address
:
Phone
:
*
E-Mail
:
*
Question/Enquiry
Infectious Disease
IQP-0410 for HIV
HBV Lead Discovery
Anti-Cancer Agents
IQP-0303 for
leukemia
IQP-0304 for prostate
cancer
Topical Microbicides
IQP-0528
IQP-0831
IQP-1187
Copyright © 2006, ImQuest Life Sciences.
Site Map
|
Search
|
Privacy Policy
|
Terms & Conditions
.
Site by Synapse Communications.
